Zinc finger nucleases for targeted mutagenesis and repair of the sickle-cell disease mutation: An in-silico study

BMC Blood Disorders

Volumn 12, Issue , 2012, Pages

  Wayengera, Misaki ^a  

^a MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

ENDONUCLEASE; GENOMIC DNA; HEMOGLOBIN BETA CHAIN; ZINC FINGER NUCLEASE;

ARTICLE; BASE PAIRING; CODON; COMPUTER MODEL; COMPUTER PROGRAM; CONTROLLED STUDY; DATA BASE; FLAVOBACTERIUM; GENE MUTATION; GENE SEQUENCE; GENETIC LINKAGE; GENOTYPE; MUTAGENESIS; NONHUMAN; SICKLE CELL ANEMIA;

EID: 84860791017     PISSN: None     EISSN: 14712326     Source Type: Journal    
DOI: 10.1186/1471-2326-12-5     Document Type: Article

References (48)

1. Ballas SK, Lewis CN, Noone AM, Krasnow SH, Kamarulzaman E, Burka ER. Clinical, hematological, and biochemical features of Hb SC disease. Am J Hemat 1982, 13:37-51. 10.1002/ajh.2830130106, 7137165.
2. Blouin M-J, Beauchemin H, Wright A, De Paepe M, Sorette M, Bleau A-M, Nakamoto B, Ou C-N, Stamatoyannopoulos G, Trudel M. Genetic correction of sickle cell disease: insights using transgenic mouse models. Nature Med 2000, 6:177-182. 10.1038/72279, 10655106.
3. Herrick JB. Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. Arch Intern Med 1910, 6:517-521.
4. Hebbel RP. Adhesive interactions of sickle erythrocytes with endothelium. J Clin Invest 1997, 99:2561-2564. 10.1172/JCI119442, 508099, 9169483.
5. Ashley-Koch A, Murphy CC, Khoury MJ, Boyle CA. Contribution of sickle cell disease to the occurrence of developmental disabilities: a population-based study. Genet Med 2001, 3:181-186. 10.1097/00125817-200105000-00006, 11388758.
6. Rees DC, Williams TN, Gladwin MT. Sickle cell disease. Lancet 2010, 376:2018-2031. 10.1016/S0140-6736(10)61029-X, 21131035.
7. Geller AK, O'Connor MK. The sickle cell crisis: a dilemma in pain relief. Mayo Clin Proc 2008, 83(3):320-323. 10.4065/83.3.320, 18315999.
8. Dunlop RJ, Bennett KC. Pain management for sickle cell disease. Cochrane Database Syst Rev 2006, 19(2):CD003350.
9. Serjeant GR. Mortality from sickle cell disease in Africa. BMJ 2005, 330(7489):432-433. 10.1136/bmj.330.7489.432, 549643, 15731125.
10. Friedman MJ, Trager W. The biochemistry of resistance to malaria. Sci Am 1981, 244(3):154-164. 10.1038/scientificamerican0381-154, 6163210.
11. Chui DHK. THAL for THAL?. Blood 2007, 110(8):2788-2789.
12. Luzzatto L, Goodfellow P. Sickle cell anemia: a simple disease with no cure. Nature 1989, 337:17-18. 10.1038/337017a0, 2909889.
13. Walters MC, Patience M, Leisenring W, Eckman JR, Scott JP, Mentzer WC, Davies SC, Ohene-Frempong K, Bernaudin F, Matthews DC, Storb R, Sullivan KM. Bone marrow transplantation for sickle cell disease. N Engl J Med 1996, 335(6):369-376. 10.1056/NEJM199608083350601, 8663884.
14. Walters MC, Storb R, Patience M, Leisenring W, Taylor T, Sanders JE, Buchanan GE, Rogers ZR, Dinndorf P, Davies SC, Roberts IA, Dickerhoff R, Yeager AM, Hsu L, Kurtzberg J, Ohene-Frempong K, Bunin N, Bernaudin F, Wong WY, Scott JP, Margolis D, Vichinsky E, Wall DA, Wayne AS, Pegelow C, Redding-Lallinger R, Wiley J, Klemperer M, Mentzer WC, Smith FO, Sullivan KM. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood 2000, 95(6):1918-1924.
15. de Montalembert M. Management of sickle cell disease. BMJ 2008, 337:a1397. 10.1136/bmj.a1397, 18779222.
16. Shesely EG, KiM H-K, Shehee RW, Papayannopoulou N, Smithies O, Popovicht BW. Correction of a human βS-globin gene by gene targeting. Proc Natl Acad Sci USA 1991, 88:4294-4298. 10.1073/pnas.88.10.4294, 51645, 2034673.
17. Lan N, Howrey RP, Lee SW, Smith CA, Sullenger BA. Ribozyme-mediated repair of sickle beta-globin mRNAs in erythrocyte precursors. Science 1998, 280(5369):1593-1596. 10.1126/science.280.5369.1593, 9616120.
18. Weatherall DJ. Gene therapy: repairing haemoglobin disorders with ribozymes. Curr Biol 1998, 8(19):R696-R698. 10.1016/S0960-9822(98)70439-7, 9768357.
19. Alami R, Gilman JG, Feng YQ, Marmorato A, Rochlin I, Suzuka SM, Fabry ME, Nagel RL, Bouhassira EE. Anti-beta s-ribozyme reduces beta s mRNA levels in transgenic mice: potential application to the gene therapy of sickle cell anemia. Blood Cells Mol Dis 1999, 25(2):110-119. 10.1006/bcmd.1999.0235, 10389593.
20. Xu L, Ferry AE, Monteiro C, Pace BS. Beta globin gene inhibition by antisense RNA transcripts. Gene Ther 2000, 7(5):438-444. 10.1038/sj.gt.3301106, 10694826.
21. Pace BS, Qian X, Ofori-Acquah SF. Selective inhibition of beta-globin RNA transcripts by antisense RNA molecules. Cell Mol Biol (Noisy-le-grand) 2004, 50(1):43-51.
22. Amosova O, Broitman SL, Fresco JR. Repairing the Sickle Cell mutation. II. Effect of psoralen linker length on specificity of formation and yield of third strand-directed photoproducts with the mutant target sequence. Nucleic Acids Research 2003, 31(16):4673-4681. 10.1093/nar/gkg659, 169896, 12907706.
23. Kmiec EB. Targeted gene repair. Gene Therapy 1999, 6(1):1-3. 10.1038/sj.gt.3300789, 10341868.
24. Lui L, Rice MC, Kmiec EB. In vivo gene repair of point and frameshift mutations directed by chimeric RNA/DNA oligonucleotides and modified single-stranded oligonucleotides. Nucleic Acids Res 2001, 29(20):4238-4250. 10.1093/nar/29.20.4238, 60207, 11600713.
25. Wayengera M. Bone marrow transplantation (BMT) and gene replacement therapy (GRT) in sickle cell anemia. Niger J Med 2008, 17(3):251-256.
26. Urnov FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD. Genome editing with engineered zinc finger nucleases. Nat Rev Genet 2010, 11(9):636-646. 10.1038/nrg2842, 20717154.
27. Cathomen T, Joung JK. Zinc-finger nucleases: the next generation emerges. Mol Ther 2008, 16(7):1200-1207. 10.1038/mt.2008.114, 18545224.
28. Guo J, Gaj T, Barbas CF. Directed Evolution of an Enhanced and Highly Efficient FokI Cleavage Domain for Zinc Finger Nucleases. Journal of Molecular Biology 2010, 400(1):96. 10.1016/j.jmb.2010.04.060, 2885538, 20447404.
29. Durai S, Mani M, Kandavelou K, Wu J, Porteus MH, Chandrasegaran S. Zinc finger nucleases: custom-designed molecular scissors for genome engineering of plant and mammalian cells. Nucl Acids Res 2005, 33(18):5978-5990. 10.1093/nar/gki912, 1270952, 16251401.
30. Porteus MH, Carroll D. Gene targeting using zinc finger nucleases. Nat Biotechnol 2005, 23(8):967-973. 10.1038/nbt1125, 16082368.
31. Perez E, Wang J, Miller JC, Jouvenot Y, Kim KA, Liu O, Wang N, Lee G, Bartsevich VV, Lee YL, Guschin DY, Rupniewski I, Waite AJ, Carpenito C, Carroll RG, Orange JS, Urnov FD, Rebar EJ, Ando D, Gregory PD, Riley JL, Holmes MC, June CH. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol 2008, 26(7):808-816. 10.1038/nbt1410, 18587387.
32. Holt N, Wang J, Kim K, Friedman G, Wang X, Taupin V, Crooks GM, Kohn DB, Gregory PD, Holmes MC, Cannon PM. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol 2010, 28(8):839-847. 10.1038/nbt.1663, 3080757, 20601939.
33. Wilen CB, Wang J, Tilton JC, Miller JC, Kim KA, Rebar EJ, Sherrill-Mix SA, Patro SC, Secreto AJ, Jordan APO1, Lee G, Kahn J, Aye PP, Bunnell BA, Lackner AA, Hoxie JA, Danet-Desnoyers GA, Bushman FD, Riley JL, Gregory PD, June CH, Holmes MC, Doms RM. Engineering HIV-Resistant Human CD4+ T Cells with CXCR4-Specific Zinc-Finger Nucleases. PLoS Pathog 2011, 7(4):e1002020. 10.1371/journal.ppat.1002020, 3077364, 21533216.
34. Cavazzana-Calvo M, Payen E, Negre O, Wang G, Hehir K, Fusil F, Down J, Denaro M, Brady T, Westerman K, Cavallesco R, Gillet-Legrand B, Caccavelli L, Sgarra R, Maouche-Chrétien L, Bernaudin F, Girot R, Dorazio R, Mulder GJ, Polack A, Bank A, Soulier J, Larghero J, Kabbara N, Dalle B, Gourmel B, Socie G, Chrétien S, Cartier N, Aubourg P, Fischer A, Cornetta K, Galacteros F, Beuzard Y, Gluckman E, Bushman F, Hacein-Bey-Abina S, Leboulch P. Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia. Nature 2010, 467(7313):318-322. 10.1038/nature09328, 3355472, 20844535.
35. Ponnazhagan S, Weigel KA, Raikwar SP, Mukherjee P, Yoder MC, Srivastava A. Recombinant human Parvovirus B19 vectors: erythroid cell-specific delivery and expression of transduced genes. J Virol 1998, 72:5224-5230. 110104, 9573295.
36. Sander JD, Maeder ML, Reyon D, Voytas DF, Joung JK, Dobbs D. ZiFiT (Zinc Finger Targeter): an updated zinc finger engineering tool. Nucl Acids Res 2010, 38:W462-W468. 10.1093/nar/gkq319, 2896148, 20435679.
37. Mandell JG, Barbas CF. Zinc finger tools: custom DNA-binding domains for transcription factors and nucleases. Nucl Acids Res 2006, 34(SI):W516-W523. 1538883, 16845061.
38. Kim Y-G, Cha J, Chandrasegaran S. Hybrid restriction enzymes: Zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci USA 1995, 93:1156-1160.
39. Dreier B, Segal DJ, Barbas CF. Insights into the molecular recognition of the 5 '-GNN-3 ' family of DNA sequences by zinc finger domains. J Mol Biol 2000, 303(4):489-502. 10.1006/jmbi.2000.4133, 11054286.
40. Herrmann F, Garriga-Canut M, Baumstark R, Fajardo-Sanchez E, Cotterell J, Minoche A, Himmelbauer H, Isalan M. p53 Gene Repair with Zinc Finger Nucleases Optimised by Yeast 1-Hybrid and Validated by Solexa Sequencing. PLoS One 2011, 6(6):e20913. 10.1371/journal.pone.0020913, 3111460, 21695267.
41. Doyon Y, Vo TD, Mendel MC, Greenberg SG, Wang J, Xia DF, Miller JC, Urnov FD, Gregory PD, Holmes MC. Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures. Nat Methods 2011, 8(1):74-79. 10.1038/nmeth.1539, 21131970.
42. Mátrai J, Chuah MK, VandenDriessche T. Recent advances in lentiviral vector development and applications. Mol Ther 2010, 18(3):477-490. 10.1038/mt.2009.319, 2839421, 20087315.
43. Silva MM, Rogers PH, Arnone A. A third quaternary structure of human hemoglobin A at 1.7-A resolution. J Biol Chem 1992, 267(24):17248-17256.
44. Shaanan B. Structure of human oxyhaemoglobin at 2.1 A resolution. J Mol Biol 1983, 171(1):31-59. 10.1016/S0022-2836(83)80313-1, 6644819.
45. Fermi G, Perutz MF, Shaanan B, Fourme R. The crystal structure of human deoxyhaemoglobin at 1.74 A resolution. J Mol Biol 1984, 175(2):159-174. 10.1016/0022-2836(84)90472-8, 6726807.
46. Okwi AL, Byarugaba W, Ndugwa CM, Parkes A, Ocaido M, Tumwine JK. An up-date on the prevalence of sickle cell trait in Eastern and Western Uganda. BMC Blood Disord 2010, 10:5. 10.1186/1471-2326-10-5, 2905339, 20569434.
47. Pattanayak V, Ramirez CL, Joung KJ, Liu DR. Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection. Nat Methods 2011, 8(9):765-770. 10.1038/nmeth.1670, 3164905, 21822273.
48. Gabriel R, Lombardo A, Arens A, Miller JC, Genovese P, Kaeppel C, Nowrouzi A, Bartholomae CC, Wang J, Friedman G, Holmes MC, Gregory PD, Glimm H, Schmidt M, Naldini L, von Kalle C. An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat Biotechnol 2011, 29(9):816-823. 10.1038/nbt.1948, 21822255.